Latest Articles
September 20, 2023
Genetics in Medicine publication demonstrates a 10% lower rate of VUS with WES/WGS compared to panels
A discussion of VUS and explanation of their significance, highlighting Ambry’s collaboration in the GIM publication, The landscape of reported VUS in multi-gene panel and…
Clinical Research
Variant of Unknown Significance
September 14, 2023
Ovarian Cancer Awareness Month Spotlight: Norma Livingston Ovarian Cancer Foundation
The Norma Livingston Ovarian Cancer Foundation (NLOCF) was founded in Birmingham, Alabama in 2004. For Ovarian Cancer Awareness month, Ambry explores its history, spotlights campaigns…
Advocacy Group
Awareness
Genetic Counselors
Genetic Testing
Hereditary Cancer
Ovarian Cancer
August 9, 2023
Her Healthcare: Leveraging the CARE Program to Scale High-Risk Patient Identification
Dr. Boyd, patient Kristi and medical assistant Briana Guro give their thoughts on the implementation of The CARE Program in their practice.
Breast Cancer
Cancer Risk
Family History
OBGYN
August 2, 2023
Her Healthcare: Offering Comprehensive Care with Hereditary Cancer Testing
Dr. Noel Boyd from Her Healthcare in Houston, TX, explains the importance of genetic testing for hereditary cancer risk,
Breast Cancer
Colorectal Cancer
Genetic Testing
OBGYN
July 18, 2023
Gene of the Month: KCNH5
How whole exome sequencing helped 2-year-old Emma receive a diagnosis for epileptic encephalopathy.
Epilepsy
Whole Exome Sequencing
June 20, 2023
A Landmark Ruling: Celebrating 10 Years of Freedom from Gene Patenting
A compilation of all the posts and videos from our celebration of the Tenth Anniversary of the SCOTUS decision ruling naturally occurring genes could not…
BRCA
BRCA1 & 2
Genetic Counselors
Genetic Testing
TRUE
![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)